Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors
References
Additional references
Jump to:
Al‐Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, et al. Emerging evidence on the pathobiology of mucositis. Supportive Care in Cancer 2013;21(11):3233‐41.
Bellm LA, Cunningham G, Durnell L, Eilers J, Epstein JB, Fleming T, et al. Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board. Cancer Investigation 2002;20(5‐6):793‐800.
Boers‐Doets CB, Raber‐Durlacher JE, Treister NS, Epstein JB, Arends AB, Wiersma DR, et al. Mammalian target of rapamycin inhibitor‐associated stomatitis. Future Oncology 2013;9(12):1883‐92.
Clarke M. Standardising outcomes for clinical trials and systematic reviews. Trials 2007;8:39.
Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One 2008;3(8):e3081.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315(7109):629‐34.
Elting LS, Keefe DM, Sonis ST, Garden AS, Spijkervet FK, Barasch A, et al. Patient‐reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer 2008;113(10):2704‐13.
Epstein JB, Emerton S, Kolbinson DA, Le ND, Phillips N, Stevenson‐Moore P, et al. Quality of life and oral function following radiotherapy for head and neck cancer. Head & Neck 1999;21(1):1‐11.
GRADE WG. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Jensen SB, Peterson DE. Oral mucosal injury caused by cancer therapies: current management and new frontiers in research. Journal of Oral Pathology & Medicine 2014;43(2):81‐90.
Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dental Clinics of North America 2008;52(1):61‐77.
Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 2014;120(10):1453‐61.
Lyman GH, Dale DC, Wolff DA, Culakova E, Poniewierski MS, Kuderer NM, et al. Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony‐stimulating factor: a systematic review. Journal of Clinical Oncology 2010;28(17):2914‐24.
Miller M, Kearney N. Oral care for patients with cancer: a review of the literature. Cancer Nursing 2001;24(4):241‐54.
Nonzee NJ, Dandade NA, Patel U, Markossian T, Agulnik M, Argiris A, et al. Evaluating the supportive care costs of severe radiochemotherapy‐induced mucositis and pharyngitis. Cancer 2008;113(6):1446‐52.
Peterson DE, Srivastava R, Lalla RV. Oral mucosal injury in oncology patients: perspectives on maturation of a field. Oral Diseases2015; Vol. 21, issue 2:133‐41.
Raber‐Durlacher JE, von Bültzingslöwen I, Logan RM, Bowen J, Al‐Azri AR, Everaus H, et al. Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Supportive Care in Cancer 2013;21(1):343‐55.
Scully C, Sonis S, Diz PD. Oral mucositis. Oral Diseases 2006;12(3):229‐41.
Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem‐cell transplantation. Journal of Clinical Oncology 2001;19(8):2201‐5.
Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer‐Jensen M, et al. Perspectives on cancer therapy‐induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004;100(9 Suppl):1995‐2025.
Sonis ST. Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncology 2009;45(12):1015‐20.
Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiotherapy and Oncology 2003;66(3):253‐62.
von Bültzingslöwen I, Brennan MT, Spijkervet FK, Logan R, Stringer A, Raber‐Durlacher JE, et al. Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis. Supportive Care in Cancer 2006;14(6):519‐27.
Williamson PR, Gamble C, Altman DG, Hutton JL. Outcome selection bias in meta‐analysis. Statistical Methods in Medical Research 2005;14(5):515‐24.
Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, et al. Developing core outcome sets for clinical trials: issues to consider. Trials 2012;13:132.
Worthington H, Clarkson J, Weldon J. Priority oral health research identification for clinical decision‐making. Evidence‐based Dentistry 2015;16(3):69‐71.
References to other published versions of this review
Jump to:
Worthington HV, Clarkson JE, Bryan G, Furness S, Glenny AM, Littlewood A, et al. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews 2011, Issue 4. [DOI: 10.1002/14651858.CD000978.pub5]
